Literature DB >> 29775203

Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data.

Rebecca Hager1, Anastasios A Tsiatis2, Marie Davidian2.   

Abstract

Clinicians often make multiple treatment decisions at key points over the course of a patient's disease. A dynamic treatment regime is a sequence of decision rules, each mapping a patient's observed history to the set of available, feasible treatment options at each decision point, and thus formalizes this process. An optimal regime is one leading to the most beneficial outcome on average if used to select treatment for the patient population. We propose a method for estimation of an optimal regime involving two decision points when the outcome of interest is a censored survival time, which is based on maximizing a locally efficient, doubly robust, augmented inverse probability weighted estimator for average outcome over a class of regimes. By casting this optimization as a classification problem, we exploit well-studied classification techniques such as support vector machines to characterize the class of regimes and facilitate implementation via a backward iterative algorithm. Simulation studies of performance and application of the method to data from a sequential, multiple assignment randomized clinical trial in acute leukemia are presented.
© 2018, The International Biometric Society.

Entities:  

Keywords:  Doubly robust; Inverse probability weighting; Optimal treatment regime; Sequential multiple assignment randomized trial; Support vector machine; Value search

Mesh:

Year:  2018        PMID: 29775203      PMCID: PMC6240504          DOI: 10.1111/biom.12894

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  17 in total

1.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

2.  Adaptive contrast weighted learning for multi-stage multi-treatment decision-making.

Authors:  Yebin Tao; Lu Wang
Journal:  Biometrics       Date:  2016-05-23       Impact factor: 2.571

3.  Q- and A-learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Authors:  Phillip J Schulte; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Stat Sci       Date:  2014-11       Impact factor: 2.901

4.  Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition Times.

Authors:  Yanxun Xu; Peter Müller; Abdus S Wahed; Peter F Thall
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

5.  A robust method for estimating optimal treatment regimes.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrics       Date:  2012-05-02       Impact factor: 2.571

6.  Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.

Authors:  Bayard L Powell; Barry Moser; Wendy Stock; Robert E Gallagher; Cheryl L Willman; Richard M Stone; Jacob M Rowe; Steven Coutre; James H Feusner; John Gregory; Stephen Couban; Frederick R Appelbaum; Martin S Tallman; Richard A Larson
Journal:  Blood       Date:  2010-08-12       Impact factor: 22.113

7.  Q-LEARNING WITH CENSORED DATA.

Authors:  Yair Goldberg; Michael R Kosorok
Journal:  Ann Stat       Date:  2012-02-01       Impact factor: 4.028

8.  New Statistical Learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Authors:  Ying-Qi Zhao; Donglin Zeng; Eric B Laber; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2015       Impact factor: 5.033

9.  Robust estimation of optimal dynamic treatment regimes for sequential treatment decisions.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrika       Date:  2013       Impact factor: 2.445

10.  STATISTICAL INFERENCE FOR THE MEAN OUTCOME UNDER A POSSIBLY NON-UNIQUE OPTIMAL TREATMENT STRATEGY.

Authors:  Alexander R Luedtke; Mark J van der Laan
Journal:  Ann Stat       Date:  2016-03-17       Impact factor: 4.028

View more
  2 in total

1.  Constructing dynamic treatment regimes with shared parameters for censored data.

Authors:  Ying-Qi Zhao; Ruoqing Zhu; Guanhua Chen; Yingye Zheng
Journal:  Stat Med       Date:  2020-01-17       Impact factor: 2.373

2.  Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selection.

Authors:  Yizeng He; Soyoung Kim; Mi-Ok Kim; Wael Saber; Kwang Woo Ahn
Journal:  Comput Stat Data Anal       Date:  2021-01-14       Impact factor: 2.035

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.